A groundbreaking victory for anyone affected by hereditary breast - TopicsExpress



          

A groundbreaking victory for anyone affected by hereditary breast and ovarian cancer. The US Supreme Court has ruled that human genes cannot be patented. This decision should have a major impact on medicine and research related to hereditary breast and ovarian cancer. As Myriad Genetics held the patent for the BRCA1 and BRCA2 gene, they controlled the cost of gene testing and how the gene was used for research. The loss of patent protection has the power to drive the price of testing down and lead to more research and development. aclu.org/blog/womens-rights-free-speech-technology-and-liberty/victory-supreme-court-decides-our-genes-belong
Posted on: Thu, 13 Jun 2013 19:21:21 +0000

Trending Topics



Recently Viewed Topics




© 2015